Introduction to Small Molecule Drug Discovery & Development (Coursera)

Introduction to Small Molecule Drug Discovery & Development (Coursera)

What does it take to advance a new drug from the laboratory bench to the patient’s bedside? Historically, drugs were discovered serendipitously and were usually isolated from natural sources. Today, drug discovery efforts take many years and cost hundreds of millions of dollars. They also require the input of dozens of specialists from a multitude of backgrounds to ensure that therapeutic molecules are efficacious and safe.

Class Deals by MOOC List - Click here and see Coursera's Active Discounts, Deals, and Promo Codes.

This four-week course takes a high-level tour of what it takes to research and develop a new drug. We will meet different scientists and professionals across the drug discovery value chain as we explore the different stages of discovery and development, including the different tools and technologies that are influencing how we think about new medicines today.
Starting off with the needs of the patient and the early phases of drug discovery, we will cover drug metabolism, pharmacokinetics and drug safety all the way to clinical development and beyond. This course is relevant for scientists who are new to drug discovery research or already have some experience, health professionals, or anyone who is interested in knowing what had to happen to ensure that their medicine is effective and safe.

What you'll learn

  • The different stages of drug discovery and development, including the tools and technologies influencing how we think about new medicines.
  • Investigate drug metabolism, pharmacokinetics and drug safety all the way to clinical development and beyond from the needs of the patient.

Syllabus

The starting point for drug discovery: The needs of the patient
This week covers an introduction to the drug discovery and development process. It starts off by considering the patient, as the ultimate beneficiary of new and improved drugs, to ensure that they are kept at the centre of and integrated into all subsequent decision-making. Through a case study, the concept of an unmet medical need is introduced and provides a backdrop for understanding further critical concepts which underlie drug discovery and development. An overview of various drug discovery strategies is presented, along with approaches to screening and hit discovery. Various scientific, medical and humanitarian considerations need to be taken into account if effective delivery of new and improved drugs is to be achieved. Some of the challenges are presented, and a panel discussion highlights different, and similar, perspectives in the academic and industry approach to drug discovery projects.

The early phases of drug discovery
This week explores the early phases of drug discovery. As outlined previously, the starting point is always the needs of the patient and their biomedical realities. Understanding disease biology is a critical next step and sets the scene for mapping the context for immune response and the origins of ill health and how the progression of disease can be controlled or arrested. Case studies, particularly in the context of tuberculosis (TB), demonstrate the rationale behind molecular biology studies of the pathogen and the host. Key concepts such as the essentiality and vulnerability of targets and their 'druggability' are introduced. Medicinal chemistry drives the chemical modification of drug-like molecules to improve their activity and safety. The various tools and approaches that the medicinal chemist has at their disposal, including the value of the screening cascade, will be discussed.

Drug metabolism, pharmacokinetics and drug safety
This week picks up the drug discovery and development story at the point at which promising drug candidates have already been identified. The crucial importance in this phase of investigating the pharmacokinetics and pharmacodynamics of potential drugs is introduced, as these are key parameters for the effectiveness of a new drug and a positive patient experience. These properties have a bearing on bioavailability and metabolic processes and provide a backdrop for animal model studies, and the extent to which the biological properties of the drug are retained in mammalian systems. The ethical considerations and technological advances pertaining to in vivo testing are discussed. Drug testing, safety profiling, and toxicology and efficacy in preparation for clinical trials are presented, and an introduction to process optimization and API manufacturing is also discussed.

Development phase
This week outlines and examines the clinical development phase. Once a drug candidate has successfully progressed through the phases outlined previously, it qualifies for filing as an Investigational New Drug (IND) and a Clinical Trial Application (CTA) and the accompanying review process. An overview is given of the regulatory framework governing this, and a description of the various phases of clinical trials. The extensive teamwork that is required during the clinical trial is outlined, as well as the various role-players in this process, and some of the critical aspects, such as the submission and approval process, protocols that need to be established, informed consent and site management, are described. Finally, we look to the future and consider how new technologies are changing the face of drug discovery and development and how this may ultimately bring newer and safer medicines to the patient more rapidly.

Go to Class
MOOC List is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Related Courses

Clinical Pharmacokinetics: Dosing and Monitoring (FutureLearn) FutureLearn
Taipei Medical University

Clinical Pharmacokinetics: Dosing and Monitoring (FutureLearn)

Understanding pharmacokinetics, from basic principles to clinical applications. Explore the key principles of pharmacokinetics and how to apply them. On this course you will learn about the principles of clinical pharmacokinetics, including factors that affect the absorption, distribution, metabolism, excretion, and binding of drugs.

Self Paced
5-12 Weeks
Pharmacology of Antibacterial Agents (Coursera) Coursera
E-Learning Development Fund,RUDN University

Pharmacology of Antibacterial Agents (Coursera)

The online course “Pharmacology of antibacterial agents” has been designed and developed by the team of authors of Department of General and Clinical Pharmacology, Medical Institute of People’s Friendship University of Russia (RUDN University). The main objective of the course is to provide systemic knowledge on pharmacokinetic and pharmacodynamic parameters of the main groups of antibacterial agents and insight into their proper and safe use.

Jul 18th 2022
5-12 Weeks
Translating Basic Research into Research for Humans (Coursera) Coursera
University of Michigan

Translating Basic Research into Research for Humans (Coursera)

The first phase of translational research — known as “T1” — is the process of moving foundational scientific discoveries into possible approaches for real-world health applications. This course focuses on innovations in basic science discovery, including drug discovery and repurposing and animal studies, that lead to new methods of diagnosis, treatment, and prevention in highly controlled settings.

Nov 16th 2026
3 Weeks
Lead Discovery & Optimization for Efficacy, PK, & Safety (edX) EdX
Davidson College,DavidsonX

Lead Discovery & Optimization for Efficacy, PK, & Safety (edX)

Understanding the efficacy, potency, pharmacokinetics, and safety of compounds is important, but compounds almost always require improvement in their properties in order to become drugs. The process of improvement is called lead optimization and requires a thorough understanding of how a molecule’s structure affects its function, whether efficacy, PK, or toxicity. Unraveling a compound’s structure-function relationship enables lead optimization and hopefully results in the discovery of a compound that can be advanced into clinical trials.

Self Paced
Self-Paced
Introduction to Pharmacokinetics: From ADME to PK/PD (edX) EdX
Davidson College,DavidsonX

Introduction to Pharmacokinetics: From ADME to PK/PD (edX)

A critical aspect of a drug involves how a drug is dosed and circulates throughout the body of a patient. These qualities are aspects of a drug’s pharmacokinetics or PK. Pharmacokinetics encompasses how a drug is absorbed and flows through a patient until it is ultimately eliminated. While pharmacokinetics covers drug behavior in a living organism, PK properties can often be predicted through laboratory tests for a compound’s ADME properties. ADME stands for absorption, distribution, metabolism, and excretion. The PK and ADME properties of potential drug are closely monitored throughout the discovery and early development stages of a drug campaign.

Self Paced
Self-Paced
Targets, Assays & Screening (Coursera) Coursera
Novartis

Targets, Assays & Screening (Coursera)

This course focuses on the early stages of drug discovery and the identification of promising compounds with which to begin the hunt for a novel drug.  Different types of assays and methods are reviewed that are used to screen libraries of molecules in the preliminary search for compounds with activity.  Methods are discussed for validating that active molecules are indeed engaging a target associated with a predicted therapeutic benefit.

Nov 16th 2026
3 Weeks
Capstone Project: Advanced AI for Drug Discovery (Coursera) Coursera
LearnQuest

Capstone Project: Advanced AI for Drug Discovery (Coursera)

In this capstone project course, we'll compare genome sequences of COVID-19 mutations to identify potential areas a drug therapy can look to target. The first step in drug discovery involves identifying target subsequences of theirs genome to target. We'll start by comparing the genomes of virus mutations to look for similarities. Then, we'll perform PCA to cut down our number of dimensions and identify the most common features.

Nov 16th 2026
3 Weeks
Pharmacokinetics (Coursera) Coursera
Novartis

Pharmacokinetics (Coursera)

This course begins with a review of routes of administration, ADME (absorption, distribution, metabolism, & excretion), and the use of in vivo drug concentration-time data to determine key pharmacokinetic parameters, like volume of distribution, half-life and clearance.  The course then emphasizes in vitro assays that allow rapid prediction of ADME and PK properties for evaluation of new compounds. 

Nov 16th 2026
3 Weeks
Case Studies in Personalized Medicine (Coursera) Coursera
Vanderbilt University

Case Studies in Personalized Medicine (Coursera)

Learn how advances in biomedicine hold the potential to revolutionize drug development, drug treatments, and disease prevention: where are we now, and what does the future hold? This course will present short primers in genetics and mechanisms underlying variability in drug responses. A series of case studies will be used to illustrate principles of how genetics are being brought to bear on refining diagnoses and on personalizing treatment in rare and common diseases. The ethical and operational issues around how to implement large scale genomic sequencing in clinical practice will be addressed.

Dec 7th 2026
5-12 Weeks